by journal – Retraction Watch

Japan institute defends Nobel Prize winner amid allegations of image duplication

The Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan is defending Nobel Prize winner Shinya Yamanaka against claims of image manipulation in multiple studies on which he was an author. The institute says questioning Yamanaka’s integrity without sufficient evidence is “completely unacceptable.”

Yamanaka shared the Nobel Prize in Physiology or Medicine in 2012 and works at CiRA.

On August 7, Gotham City Research LLC, a short-selling firm based in the United States, released a report alleging image manipulation in several papers by Yamanaka appearing between 2000 and 2020.

Elsevier to ‘soon investigate’ two Macchiarini papers more than a year after retraction request

Elsevier says it will begin investigating two papers coauthored by disgraced surgeon Paolo Macchiarini “soon,” more than a year after two critics of his work formally requested the publisher retract the articles — and nearly a decade after two institutions found him guilty of misconduct for related work.

The papers, published in Biomaterials in 2009 and 2010, include descriptions of a 2008 trachea transplant in Barcelona conducted by Macchiarini — described in The Lancet that year, as well as in a five-year follow-up published in 2013. Both Lancet papers reported a successful surgery and that the patient had a “normal social and working life.” In reality, she needed stents, her lung function did not improve and she eventually had a lung removed.

The Barcelona patient survived, but at least three others who underwent Macchiarini’s synthetic trachea transplants eventually died. In 2023, a Swedish court sentenced Macchiarini to 2.5 years in prison for gross assault related to his failed transplants. So far he has accumulated 13 retractions.

JAMA journal won’t retract oxycodone paper despite author request, citing no ‘falsification’

JAMA Internal Medicine has rejected a petition by a group of clinicians calling for the journal to retract an article on oxycodone therapy for osteoarthritis. The request — which initially included two of the paper’s original authors — stems from 19-year-old court records revealing the sponsor of the study withheld evidence about opioid withdrawal that contradicted the paper’s conclusions.

Published in 2000 under the journal’s previous name, Archives of Internal Medicine, the study of 133 patients concluded that around-the-clock, controlled-release oxycodone was safe and effective for managing osteoarthritis pain and that withdrawal symptoms were rare. In 2007, documents made public during a federal criminal case against Purdue Frederick Company, the maker of OxyContin, showed the company concealed how many patients became dependent on the drug during the trial and omitted withdrawal data. Purdue pleaded guilty in 2007 to fraudulently marketing OxyContin with the intent to mislead, agreeing to pay the government more than $600 million in penalties.

Despite the withdrawal data being made public nearly 20 years ago, the study has remained in the scientific literature without changes, Andrew Kolodny told Retraction Watch. Kolodny is medical director for the Opioid Policy Research Collaborative at Brandeis University and president of Physicians for Responsible Opioid Prescribing. Kolodny has also testified before Congress about the opioid epidemic, assisted federal authorities with investigating the opioid industry and pain organizations, and acted as an expert witness for plaintiffs in litigation against opioid makers.

Biology journal pulls 100+ articles and counting from special issues for peer review manipulation

Elsevier’s International Journal of Biological Macromolecules has issued more than 100 retractions and counting for manipulated peer review in guest-edited special issues. The publisher has said one more retraction is coming.

Since June the publisher has retracted 120 papers. According to the retraction notices, the journal identified “[s]ystematic, coordinated, and widespread manipulation of the peer-review process.”

A spokesperson for Elsevier told Retraction Watch the publisher “became aware of possible systematic manipulation and other issues such as plagiarism, image duplication, and authorship issues in a number of articles published in Special Issues” in 2025, which led them to conduct a wider investigation into more recent special issues.

BMJ Group retracts paper on COVID-19 vaccines and mortality featured in Senate hearing

BMJ Public Health has retracted a paper some — including a witness at a recent U.S. Senate subcommittee hearing — have used to link COVID-19 vaccines to deaths. The action comes more than two years after a researcher cited in the work flagged issues with the study.

Published May 6, 2024, the paper used the “Our World in Data” database and the World Mortality Dataset to look at COVID-19 related deaths during the height of the pandemic. News outlets covered it, from The Telegraph — “vaccines may have helped fuel rise in excess deaths” — to the New York Post, which quoted the paper’s statements about reported “serious injuries and deaths following vaccination,” a move it later corrected.

An expression of concern, placed on the paper about a month after it was published, attempted to quell these claims, noting the study “does not establish any such link.” The notice also announced an institutional investigation by the Princess Máxima Center in the Netherlands, where three of the four authors worked, including corresponding author Saskia Mostert.

High-profile anesthesiologists earning retractions for data, image problems

In July 2021, John Loadsman received a manuscript about a clinical trial that immediately roused his suspicion. Then the editor-in-chief of Anaesthesia and Intensive Care, Loadsman asked the authors for the raw data.

They weren’t pretty. “When I looked carefully at the spreadsheet, I could see entire blocks of data that were repeated,” recalled Loadsman, an anesthesiologist and scientific sleuth at the University of Sydney. “It was obvious that this was cooked.”

He rejected the manuscript, informing both the corresponding author, Reyhan Polat of the University of Health Sciences in Ankara and Etlik City Hospital, in Turkey, and her institution about his concerns. He also made a mental note to have a look at the researcher’s published work. Over the following years, that effort drew in another sleuth and eventually prompted inquiries into more than two dozen papers by a network of researchers in Turkey.

Kaggle removes problematic stroke dataset for copyright infringement

Images from the now-deleted dataset on Kaggle purportedly showed people who had a stroke, but the folder included stock images and photos of politicians and celebrities, as seen in this screenshot.

The online data repository Kaggle has removed a problematic dataset for violating intellectual property rights months after it was flagged by sleuths for containing celebrity photos and lacking information on data provenance or confirmed medical diagnoses.

Researchers had used the images to train machine learning algorithms to detect stroke, but the dataset instead contained images of people with Bell’s palsy — as well as pictures of celebrities from movies and on the red carpet, as we reported in May. Adrian Barnett, a medical statistician at Queensland University of Technology in Australia, flagged the dataset after discovering two others he and his colleagues investigated in a February preprint that showed signs of being fabricated.

Using a reverse image search, Barnett matched four of the photos in the dataset, called “Facial droop and facial paralysis image,” to a paper published years earlier in the Journal of the Canadian Dental Association (JCDA). Only after prompting the journal to complain to Kaggle did the company take down the dataset.

Exclusive: News outlet killed story on plagiarism allegations after Cambridge prof hired law firm

Jason Arday

In September 2025, Times Higher Education had a bombshell story in the works: A star sociology professor at the University of Cambridge had allegedly plagiarized parts of his Ph.D. thesis and several journal articles. In one of the articles, the borrowed text appeared in quotes from subjects the professor, Jason Arday, claimed to have interviewed himself.

But after Arday enlisted Carter-Ruck, one of the United Kingdom’s leading defamation law firms, to send Times Higher Education a letter, the publication spiked the story, according to three sources who spoke to Retraction Watch.

One of the sources was David Sanders, a biochemist at Purdue University in Indiana, and a sleuth who contributes to the Times Higher Education on topics related to academic misconduct. He reviewed a 63-page dossier of text comparisons prepared by the publication last year and came back with his own findings. “There is no question that there is extensive plagiarism,” Sanders told us.

Journal investigating apparent data mismatch in climate study

A leading environmental economics journal is looking into claims that a 2025 study linking national innovation to lower carbon emissions contains data that does not match its source, after an expert in the field requested the paper be retracted.

The article appeared in Ecological Economics, the journal for the International Society for Ecological Economics and published by Elsevier. The authors, three researchers at ESSCA School of Management in Lyon, claimed to draw on data from 229 countries between 2013 and 2020 and reported a negative relationship between a country’s “innovativeness” and its carbon dioxide emissions per capita. The paper has been cited five times, according to Clarivate’s Web of Science.

But three months after it was published, in October 2025, the journal began investigating anomalies in the dataset, although the authors maintain none of it was fabricated. In a letter to the journal’s editors requesting a retraction last October, seen by Retraction Watch, an academic with expertise in the field who reviewed the dataset said the paper had “serious data integrity concerns” and described a “clear case of research misconduct.”

Journal retracts breast cancer paper 10 years after sleuth flagged issues

A biomedical journal has retracted a paper by a cancer researcher who sued her former institution over misconduct allegations. The action comes a decade after a sleuth first raised concerns about the article.

Former Ohio State researcher Flavia Pichiorri criticized how the publication, the Journal of Experimental Medicine, handled the dispute and said the journal suddenly pivoted away from its plan to republish the study with repeated experiments, a claim supported by correspondence seen by Retraction Watch.

In 2020, Ohio State University found Pichiorri, who worked in the lab of Carlo Croce, culpable for manipulating and reusing images in four publications, spanning from her time in Croce’s lab through establishing her own lab at Ohio State. Croce was cleared of direct misconduct, but OSU found serious management and oversight failures in his laboratory. Once a high-profile cancer researcher at Ohio State, Croce now has 18 retractions. He has filed several defamation lawsuits unsuccessfully, and reportedly owes his attorneys more than $1 million.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: